$AMRX

3 Growth Companies With Insider Ownership Up To 38%

Quantum Computing Inc. (QUBT) and Amneal Pharmaceuticals (AMRX) are highlighted for high insider ownership (11.2% and 38.2%) and growth potential. QUBT expects 59.2% annual revenue growth, while AMRX raised 2026 earnings guidance and reported strong Q2 results. Tutor Perini (TPC) also shows growth, with significant contracts and double-digit revenue growth guidance for 2026.

Original reporting
Published Aug 28, 2026, 5:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 29, 2026, 11:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AMRX
Bullish
medium confidence
Mentioned
$AMRX · $TPC
Relevance
4/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$AMRXBullishLow
01

Why it matters

Provides a quick overview of companies that may attract interest due to insider stakes and recent earnings or contract news, but lacks deep new information.

02

Market read

While the companies show solid fundamentals, the article serves more as a thematic list than a source of fresh market-moving news.

03

What to watch

Insider selling activity and lack of recent price-sensitive announcements reduce immediate catalyst strength.

Relevance 4/10Novelty 2/10Timing: none

Background

The article lists three U.S. growth companies with notable insider ownership, providing brief financial snapshots and recent developments.

Company-level read

Ticker impact

$AMRXBullishMedium confidence
Context

Amneal raised its 2026 earnings guidance and reported strong Q2 results with net income more than doubling YoY, plus FDA approvals for new injections.

Expected impact

Potential short-term rally as investors price in higher earnings outlook.

Evidence & confidence

Guidance lift and FDA approvals are fresh data points that could attract buying, but the article is a generic list, limiting immediacy.

$TPCBullishLow confidence
Context

Tutor Perini posted strong Q2 results with improved net income and secured a $69.5M Death Valley project and a $651.8M NAVFAC Pacific task order.

Expected impact

May see modest price uptick on news of new contracts and earnings beat.

Evidence & confidence

While contracts are sizable, the article is a broad list without fresh exclusive disclosure, limiting actionable impact.

Market effects

Highlights growth potential in biotech and construction sectors with high insider ownership.

U.S. market focus; limited broader regional effect.

Minimal, as the piece is a generic list without macro implications.

Counterpoint

High insider ownership may signal limited float and potential volatility, cautioning against blind buying.

Key entities

  • Amneal Pharmaceuticals, Inc.

    Biopharma with 38.2% insider ownership, raised guidance and reported strong Q2 results.

  • Tutor Perini Corporation

    Construction firm with 14.2% insider ownership, posted strong Q2 earnings and new contracts.

  • Quantum Computing Inc.

    Photonics firm with 11.2% insider ownership, pursuing acquisitions and partnerships.

Related articles

$TPCMed

Can TPC's $4.6B Indo-Pacific Pipeline Fuel Its Next Growth Leg?

Tutor Perini Corporation (TPC) highlights a $4.6B pipeline of federal infrastructure opportunities in the Indo-Pacific region over the next 12-18 months, with an additional $1B identified beyond that. The company has already secured $1.7B in new awards, including a $652M project at Naval Base Guam, bringing its backlog to $19.9B. TPC's strategy focuses on profitability, with selective bidding and higher margins. The Indo-Pacific region is a key growth area for the company, supported by its Guam-

$AMRXMed

Amneal builds end-to-end biosimilars capacity in the U.S.

Amneal Pharmaceuticals acquired Kashiv BioSciences, expanding its U.S. biosimilars capabilities. The deal adds a Chicago R&D and manufacturing facility, and Amneal now has over 150,000 sq. ft. of space in New Jersey. The Association for Accessible Medicines says this could strengthen domestic pharmaceutical manufacturing and increase competition in the biosimilars market.

$TPCHighAI 8/10

Tutor Perini (TPC) Q2 2026 Earnings Call Transcript

Tutor Perini (TPC) reported Q2 2026 revenue of $1.6B, up 19% YoY, and adjusted EPS of $1.74, up 23% YoY. GAAP EPS rose 224% YoY to $1.23. Operating cash flow reached $334.1M for H1 2026. Backlog stood at $19.9B. The company refinanced debt, saving $21M annually, and increased its dividend by 50% to $0.09 per share. Management highlighted a $200B project pipeline and nine mega projects worth $16B. TPC was added to the S&P SmallCap 600 and S&P 1000 indices.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.

$TPCMedAI 8/10

Tutor Perini wins $60M Coast Guard contract in Florida

Tutor Perini (NYSE:TPC) said the U.S. Coast Guard awarded it a $60 million contract for design-build and waterfront maintenance in St. Petersburg, Florida. The work includes Fast Response Cutter and Waterways Commerce Cutter facilities, mooring recapitalization, navigation yard upgrades, demolitions, and new training and crew facilities, per a DHS Coast Guard notice dated Aug. 13, 2026.